Agreement between clinical practice guidelines for management of community-acquired pneumonia. A retrospective study of 101 patients;Concordance des recommandations de prise en charge des pneumonies aiguës communautaires: Étude rétrospective sur un échantillon de 101 patients hospitalisés

Revue des Maladies Respiratoires

Volumn 20, Issue 6 I, 2003, Pages 858-870

  Labarere J ^a   Fourny, M ^a   Pavese, P ^a   Bedouch, P ^a   Brambilla, C ^a   Francois P ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Antibiotics; Community acquired infection; Cross sectional studies; Guidelines for clinical practice; Pneumonia

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFOTAXIME; CEFTRIAXONE; CIPROFLOXACIN; ERYTHROMYCIN; OFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; PRISTINAMYCIN; ROXITHROMYCIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PRACTICE GUIDELINE; TREATMENT PLANNING;

ACUTE DISEASE; AGED; ANTI-BACTERIAL AGENTS; CANADA; COMMUNITY-ACQUIRED INFECTIONS; CONSENSUS; EUROPE; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PNEUMONIA; PRACTICE GUIDELINES; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 0742285360     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. BTS Guidelines for the Management of Community Acquired Pneumonia in Adults. Thorax 2001; 56: IV1-64.
2. Dean NC, Suchyta MR, Bateman KA, Aronsky D, Hadlock CJ: Implementation of admission decision support for community-acquired pneumonia. Chest 2000; 117: 1368-77.
3. Feagan BG, Marrie TJ, Lau CY, Wheeler SL, Wong CJ, Vandervoort MK: Treatment and outcomes of community-acquired pneumonia at Canadian hospitals. CMAJ 2000; 162: 1415-20.
4. Jokinen C, Heiskanen L, Juvonen H, Kallinen S, Kleemola M, Koskela M, Leinonen M, Ronnberg PR, Saikku P, Sten M, Tarkiainen A, Tukiainen H, Pyorala K, Makela PH: Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland. Clin Infect Dis 2001; 32: 1141-54.
5. Gilbert K, Gleason PP, Singer DE, Marrie TJ, Coley CM, Obrosky DS, Lave JR, Kapoor WN, Fine MJ: Variations in antimicrobial use and cost in more than 2 000 patients with community-acquired pneumonia. Am J Med 1998; 104: 17-27.
6. Angus DC, Marrie TJ, Obrosky DS, Clermont G, Dremsizov TT, Coley C, Fine MJ, Singer DE, Kapoor WN: Severe Community-acquired Pneumonia: use of Intensive Care Services and Evaluation of American and British Thoracic Society Diagnostic Criteria. Am J Respir Crit Care Med 2002; 166: 717-23.
7. Woodhead M, Macfarlane J: Local antibiotic guidelines for adult community-acquired pneumonia (CAP): a survey of UK hospital practice in 1999. J Antimicrob Chemother 2000; 46: 141-3.
8. Woodhead M. Community-acquired pneumonia guidelines - an international comparison: a view from Europe. Chest 1998; 113: 183-7.
9. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, Coley CM, Marrie TJ, Kapoor WN: A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336: 243-50.
10. Siegel S, Castellan J: Nonparametric statistics for the behavioral sciences. Mac Graw Hill, New York, 1988, 399 p.
11. Agence Française de Sécurité Sanitaire des Produits de Santé. Antibiothérapie par voie générale en pratique courante: infections ORL et respiratoires basses. AFSSAPS, Paris, 1999.
12. Heffelfinger JD, Dowell SF, Jorgensen JH, Klugman KP, Mabry LR, Musher DM, Plouffe JF, Rakowsky A, Schuchat A, Whitney CG: Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Arch Intern Med 2000; 160: 1399-408.
13. Bartlett JG, Breiman RF, Mandell LA, File TM, Jr: Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America. Clin Infect Dis 1998; 26: 811-38.
14. American Thoracic Society: Guidelines for the management of adults with community-acquired pneumonia. Am J Respir Crit Care Med 2001; 163: 1730-54.
15. American College of Emergency Physicians. Clinical policy for the management and risk stratification of community-acquired pneumonia in adults in the emergency department. Ann Emerg Med 2001; 38: 107-13.
16. Bartlett JG, Dowell SF, Mandell LA, File Jr TM, Musher DM, Fine MJ: Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis 2000; 31: 347-82.
17. Mandell LA, Marrie TJ, Grossman RF, Chow AW, Hyland RH: Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group. Clin Infect Dis 2000; 31: 383-421.
18. Société de Pathologie Infectieuse de Langue Française. Quelle doit être l'antibiothérapie de première intention des pneumonies aigues communautaires? Quelle doit être sa réévaluation en cas d'échec, compre tenu de l'évolution des agents responsables, des résistances du pneumocoques et cela justifie-t-il des associations? Révision de la IVème conférence de consensus en thérapeutique anti-infectieuse de la Société de Pathologie Infectieuse de Langue Française. Med Mal Infect 2000; 30: 573-80.
19. Huchon G, Chidiac C, Delaval P, Leophonte P, Mouton Y, Roche N, Tremolieres F: Conduite à tenir devant une infection respiratoire basse communautaire de l'adulte. Recommandations élaborées par la Société de Pneumologie de Langue Française avec la collaboration de la Société de Pathologie Infectieuse de Langue Française. Rev Mal Respir 1999; 16: 224-33.
20. Task Force Report. Guidelines for management of adult community-acquired lower respiratory tract infections. European Respiratory Society. Eur Respir J 1998; 11: 986-91.
21. Fahey TP, Peters TJ: What constitutes controlled hypertension? Patient based comparison of hypertension guidelines. BMJ 1996; 313: 93-6.
22. Unwin N, Thomson R, O'Byrne AM, Laker M, Armstrong H: Implications of applying widely accepted cholesterol screening and management guidelines to a British adult population: cross sectional study of cardiovascular disease and risk factors. BMJ 1998; 317: 1125-30.
23. Woolf SH: Practice guidelines, a new reality in medicine. II. Methods of developing guidelines. Arch Intern Med 1992; 152: 946-52.
24. Woodhead M: Community-acquired pneumonia guidelines: much guidance, but not much evidence. Eur Respir J 2002; 20: 1-3.
25. Woodhead M: Community-acquired pneumonia in Europe: causative pathogens and resistance patterns. Eur Respir J 2002; 36: 20-7.
26. Lomas J, Anderson G, Enkin M, Vayda E, Roberts R, MacKinnon B: The role of evidence in the consensus process. Results from a Canadian consensus exercise. JAMA 1988; 259: 3001-5.
27. Gleason PP, Meehan TP, Fine JM, Galusha DH, Fine MJ: Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia. Arch Intern Med 1999; 159: 2562-72.
28. Dean NC, Silver MP, Bateman KA, James B, Hadlock CJ, Hale D: Decreased mortality after implementation of a treatment guideline for community-acquired pneumonia. Am J Med 2001; 110: 451-7.
29. Whittle J, Fine MJ, Joyce DZ, Lave JR, Young WW, Hough LJ, Kapoor WN: Community-acquired pneumonia: can it be defined with claims data? Am J Med Qual 1997; 12: 187-93.